Li Xin Wang

Bank of Guangzhou Co., Ltd. engages in the provision of banking services such as personal, corporate, Internet finance, financial market, and credit card business. Its business activities include absorbing public deposits; issuing short-term, medium-term and long-term loans; handling domestic and foreign settlements; handling bill acceptance and discount; issuing financial bonds; providing letter of credit and guarantees; and interbank borrowing. The company was founded on September 11, 1996 and is headquartered in Guangzhou, China.

Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China.